Mini reviewAntagonists and agonists at the glycine site of the NMDA receptor for therapeutic interventions

Add time:09/25/2019    Source:sciencedirect.com

For decades neuroreceptor research has focused on the development of NMDA glycine-site antagonists, after Johnson and Ascher found out in 1987 about the co-agonistic character of this achiral amino acid at the NMDA receptor. Contrary to the inhibitory glycine receptor (glycineA) the glycine binding site on the NMDA receptor (glycineB) is strychnine-insensitive. A great diversity of diseases showing a disturbed glutamate neurotransmission have been linked to the NMDA receptor. Glycine site antagonists have been investigated for acute diseases like stroke and head trauma as well as chronic ones like dementia and chronic pain.

We also recommend Trading Suppliers and Manufacturers of N-(Methoxycarbonyl)glycine (cas 1670-97-9). Pls Click Website Link as below: cas 1670-97-9 suppliers

Prev:6-Oxy-(N-succinimidyl acetate)-9-(2′-methoxycarbonyl)fluorescein as a new fluorescent labeling reagent for aliphatic amines in environmental and food samples using high-performance liquid chromatography
Next:Research paperAn optimised series of substituted N-phenylpyrrolamides as DNA gyrase B inhibitors)